fibrinopeptide-a and Kidney-Diseases

fibrinopeptide-a has been researched along with Kidney-Diseases* in 4 studies

Reviews

2 review(s) available for fibrinopeptide-a and Kidney-Diseases

Article	Year
Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics. Biotechnology (Reading, Mass.), 1991, Volume: 19 Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Arteriosclerosis; Dogs; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Humans; Kidney Diseases; Neoplasms; Pregnancy; Pregnancy Complications; Radioimmunodetection; Thrombosis	1991
Progress in the measurement of circulating fibrinogen derivatives. Progress in clinical pathology, 1984, Volume: 9 Topics: Chemical Phenomena; Chemistry; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinopeptide A; Fibrinopeptide B; Humans; Kidney Diseases; Kinetics; Methods; Pulmonary Embolism; Solubility; Thrombin; Thrombophlebitis	1984

Article

Year

Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics.

Biotechnology (Reading, Mass.), 1991, Volume: 19

Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Arteriosclerosis; Dogs; Enzyme-Linked Immunosorbent Assay; Epitopes; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Fibrinopeptide A; Humans; Kidney Diseases; Neoplasms; Pregnancy; Pregnancy Complications; Radioimmunodetection; Thrombosis

1991

Progress in the measurement of circulating fibrinogen derivatives.

Progress in clinical pathology, 1984, Volume: 9

Topics: Chemical Phenomena; Chemistry; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysin; Fibrinopeptide A; Fibrinopeptide B; Humans; Kidney Diseases; Kinetics; Methods; Pulmonary Embolism; Solubility; Thrombin; Thrombophlebitis

1984

Other Studies

2 other study(ies) available for fibrinopeptide-a and Kidney-Diseases

Article	Year
The significance of fibrinogen derivatives in plasma in human renal failure. British journal of haematology, 1984, Volume: 56, Issue:2 The concentrations in plasma of fibrinogen derivatives fibrinopeptide A (FPA), beta 15-42 antigen and fragment E (FgE) antigen have been determined in patients with renal failure and compared to the concentrations of the platelet release products, beta-thromboglobulin (beta TG) and platelet factor 4 (PF4). In 'partial renal failure' (51Cr-EDTA clearance rate 4-60 ml/min) FPA, beta 15-42 antigen, FgE antigen and beta TG levels were significantly raised above a normal laboratory control group. These levels were further raised in a group of patients whose disease required regular maintenance haemodialysis (51Cr-EDTA clearance rate less than 4 ml/min). PF4 levels were not significantly raised in either group. A statistical analysis of all patient results revealed that FPA, beta 15-42 antigen and FgE antigen levels all correlated with beta TG levels but not with PF4 levels. It is known that beta TG is catabolized by the kidney but PF4 is not and that elevated beta TG levels in renal failure are caused by impaired elimination rather than increased production. These results suggest that the plasma levels of these three fibrinogen derivatives are elevated in renal disease at least in part by decreased elimination rather than by increased thrombin and plasmin activities alone. Topics: Adolescent; Adult; Aged; beta-Thromboglobulin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Kidney Diseases; Middle Aged; Peptide Fragments; Platelet Factor 4; Renal Dialysis	1984
[Measurement of urinary fibrinopeptide A (FPA)--clinical application, especially to renal disease (author's transl)]. Nihon Jinzo Gakkai shi, 1979, Volume: 21, Issue:10 Topics: Female; Fibrinogen; Fibrinopeptide A; Humans; Kidney Diseases; Male; Radioimmunoassay	1979

Article

Year

The significance of fibrinogen derivatives in plasma in human renal failure.

British journal of haematology, 1984, Volume: 56, Issue:2

The concentrations in plasma of fibrinogen derivatives fibrinopeptide A (FPA), beta 15-42 antigen and fragment E (FgE) antigen have been determined in patients with renal failure and compared to the concentrations of the platelet release products, beta-thromboglobulin (beta TG) and platelet factor 4 (PF4). In 'partial renal failure' (51Cr-EDTA clearance rate 4-60 ml/min) FPA, beta 15-42 antigen, FgE antigen and beta TG levels were significantly raised above a normal laboratory control group. These levels were further raised in a group of patients whose disease required regular maintenance haemodialysis (51Cr-EDTA clearance rate less than 4 ml/min). PF4 levels were not significantly raised in either group. A statistical analysis of all patient results revealed that FPA, beta 15-42 antigen and FgE antigen levels all correlated with beta TG levels but not with PF4 levels. It is known that beta TG is catabolized by the kidney but PF4 is not and that elevated beta TG levels in renal failure are caused by impaired elimination rather than increased production. These results suggest that the plasma levels of these three fibrinogen derivatives are elevated in renal disease at least in part by decreased elimination rather than by increased thrombin and plasmin activities alone.

Topics: Adolescent; Adult; Aged; beta-Thromboglobulin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinopeptide A; Humans; Kidney Diseases; Middle Aged; Peptide Fragments; Platelet Factor 4; Renal Dialysis

1984

[Measurement of urinary fibrinopeptide A (FPA)--clinical application, especially to renal disease (author's transl)].

Nihon Jinzo Gakkai shi, 1979, Volume: 21, Issue:10

Topics: Female; Fibrinogen; Fibrinopeptide A; Humans; Kidney Diseases; Male; Radioimmunoassay

1979